By Iain Gilbert
Date: Thursday 30 Apr 2026
(Sharecast News) - Information assurance firm NCC Group said on Thursday that first‑half trading was in line with internal expectations, with revenue, margins and earnings all improving year‑on‑year.
By Abigail Townsend
Date: Wednesday 29 Apr 2026
(Sharecast News) - GSK posted above-forecast first-quarter profits on Wednesday, boosted by robust demand for its specialist HIV and oncology drugs.
By Iain Gilbert
Date: Tuesday 28 Apr 2026
(Sharecast News) - Pharmaceutical giant GSK said on Tuesday that the US Food and Drug Administration had accepted its new drug application for bepirovirsen for priority review, with the drug being assessed as a potential treatment for adults with chronic hepatitis B.
| Price | 5,863.90 |
| Change Today | 1.64 |
| % Change | 0.03 % |
| 01-May-26 Close | 5,863.90 |
You are here: research